Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 02, 2025 08:45 ET | Source: Palisade Bio, Inc.

Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec, MD, AGAF as Vice President, Clinical Development

Veteran gastroenterologist and clinical development leader with deep expertise driving global Phase 2/3 programs across immunology, neurology, and gastrointestinal disease Carlsbad, CA, Dec. ...
November 17, 2025 01:00 ET | Source: AKAMPION

Captain T Cell Closes Financing Round to Advance its Proprietary, Next-Generation TCR-T Pipeline Into the Clinic

Available funding totaling EUR 20 million dedicated to developing novel solid tumor treatments addressing a high unmet medical needSpringboard Health Angels, Pluton Asset Holding AG, Sintra Limited,...
November 05, 2025 11:27 ET | Source: Research and Markets

Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Market Review 2025: UAE Phase 2 Progress, Microneedle Drug-Delivery Advancements, and FDA Type C Meeting Request

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Basal Cell Carcinoma (Basal Cell Epithelioma) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's...
November 03, 2025 05:54 ET | Source: Research and Markets

Breast Cancer Antibody Drug Conjugates Market Research 2025-2030: $7 Billion Market Led by Daiichi Sankyo and AstraZeneca, with Rising Competition from Roche, Pfizer/Seagen, ADC Therapeutics

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Breast Cancer Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials Insight 2030" report has been added...
October 21, 2025 05:34 ET | Source: Research and Markets

Tumor Infiltrating Lymphocytes Therapy Market Research Report 2025-2030: Market Driven by Active R&D from Iovance Biotherapeutics, Juncell Therapeutics, Biosyngen, and Instil Bio

Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "Global Tumor Infiltrating Lymphocytes Therapy Market Opportunity, Proprietary Technologies Platforms & Clinical Trials Insight 2030" report has...
October 20, 2025 09:54 ET | Source: Research and Markets

DNA Cancer Vaccine Clinical Trials & Market Opportunity Outlook 2026 | First Commercial Approval of DNA Cancer Vaccine Anticipated by 2030

Dublin, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The "DNA Cancer Vaccine Clinical Trials, Development Technology Platforms & Market Opportunity Outlook 2026" report has been added to ...
October 10, 2025 04:54 ET | Source: Research and Markets

Menin Inhibitors Drug Market Report 2025: Price, Sales & Clinical Trials Insights 2024-2028 - Kura Oncology & Kyowa Kirin Progress with New Drug Applications

Dublin, Oct. 10, 2025 (GLOBE NEWSWIRE) -- The "Menin Inhibitors Drug Market, Price, Sales & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering.Report...
October 01, 2025 05:13 ET | Source: Research and Markets

CD47 Inhibitors Drug Market & Clinical Trials Insight 2026, Featuring Adagene, Akeso, ALX Oncology, EpicentRx, ImmuneOncia, ImmuneOnco Biopharma, Phanes Therapeutics, Virtuoso Therapeutics, and More

Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "CD47 Inhibitors Drug Market Opportunity, Clinical Application by Indications & Clinical Trials Insight 2026" report has been added to ...
October 01, 2025 04:11 ET | Source: Research and Markets

Lymphoma Antibody Drug Conjugates Market Clinical Trials Insight 2030, by Company, Country, Indication and Phase

Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Lymphoma Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials Insight 2030" report has been added to ...
September 22, 2025 13:00 ET | Source: Applied Pharmaceutical Innovation (API)

API Launches the Life Sciences Placement Program in Partnership with Mitacs at the Life Sciences Week Kick-Offs

In partnership with Mitacs, Applied Pharmaceutical Innovation (API) launched the Life Sciences Placement Program, set to provide 1,000 new internships.